Fda Reevaluating Whether Over The

Phenylephrine, a key ingredient in many popular

Listen to our latest insightful conversation

Original Air Date: Monday, August 1, 2022 With the recent news about trofinetide's new drug application (NDA) submitted to the ...

Learn directly from the

This session provided a brief overview of the Request for Reconsideration (RFR) process at the Division level under Generic User ...

Healthcare professionals can comment “SAFE” for more information about supporting the SAFE Drugs Act. The

The

Dr. Emily Morris, mathematical statistician at

We explore a transformative rule for the

Learn directly from the

Traditional clinical trial and drug review approaches may not always reflect the realities of rare disease treatment development, ...

This presentation reviewed the comparative analyses (CA) process and provided key principles for conducting effective ...

FDA

The

This Consumer Update video explains the importance of reporting problems to

The Food and Drug Administration is

FDA

FDA

The Generic Drugs Forum's third of four Q&A discussion panels, bringing together the speakers from the third session of day one.